Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3297836 | 0.85 | APLNR (0.44) | HSD17B10IDO1ADRA1ATAAR1ALDH1A1 | |
| SCHEMBL3300274 | 0.84 | NQO1 (0.45) | HSD17B10ALDH1A1 | |
| SCHEMBL3302669 | 0.81 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1 | |
| SCHEMBL3300291 | 0.77 | POLB (0.38) | L3MBTL1ALDH1A1 | |
| SCHEMBL12431134 | 0.76 | HSD17B10 (0.48) | HSD17B10IDO1ADRA1ATAAR1HTR2A | |
| SCHEMBL3302017 | 0.75 | CA12 (0.56) | HSD17B10ALDH1A1 | |
| SCHEMBL3301644 | 0.75 | GAA (0.41) | HSD17B10ALDH1A1 | |
| SCHEMBL12325303 | 0.74 | MPO (0.49) | HSD17B10IDO1ADRA1ATAAR1ALDH1A1 | |
| SCHEMBL3293251 | 0.72 | CA12 (0.58) | IDO1ADRA1ATAAR1ALDH1A1 | |
| SCHEMBL9886155 | 0.72 | HSD17B10 (0.46) | HSD17B10IDO1ADRA1ATAAR1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7741393-B2 | Organic silicon-based compound and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | ARSA, OR10J3, HDAC10 | HSD17B10 955/4885IDO1 147/4885ADRA1A 2933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.